Blood Glucose Test Strip Market Trends, Growth And Share Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast Till 2032
ID: MRFR/MED/0470-CR | 80 Pages | Author: Rahul Gotadki| February 2021
Global Blood Glucose Test Strip Market Overview
The Blood Glucose Test Strip Market Size was valued at USD 18.14 Billion in 2023. The Global Blood Glucose Test Strip industry is projected to grow from USD 19.11 Billion in 2024 to USD 33.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.43% during the forecast period (2024 - 2032). Blood glucose test strip are small disposable strip that are used in conjunction with blood glucose meters for monitoring and controlling diabetes. These strip have glucose oxidase impregnated on them, which when reacts with glucose present in the blood produces gluconic acid. For this, a thin paper or plastic strip called blood glucose test strip are employed to check blood glucose levels and assist in managing diabetes.
In the medical diagnostics industry, diabetes test strip are indispensable, particularly for blood sugar monitoring and urinalysis. Test strip are composed of several strata, which comprise hydrophilic inner, adhesive, and electrode layers, in addition to a stable outer layer. Such diabetic blood test strip enable diabetic patients to effectively manage their condition by monitoring and regulating their glucose levels. Prediabetics and diabetics can routinely monitor their blood sugar levels without having to attend a clinic or diagnostic laboratory by using test strip. Apart from this, urine test strip play a vital role in medical diagnostics, specifically in the detection of urinary tract infections and the monitoring of kidney function. The test strip are capable of identifying a range of substances, including proteins, glucose, and ketones, in the urine.
In February 2023, Afon released another teaser for its non-invasive glucose monitor: this time it was a rendered image of the sensor accompanied by connected devices and modified accessories. Up to ten times daily, millions of diabetics must prick their extremities with lancets to obtain blood samples for analysis; this causes discomfort and tissue scarring. The Afon Blood Glucose Sensor is advertised as an alternative method that is both painless and non-invasive. As it could provide potentially life-saving information to millions of users in the future, it is critical that any company involved in this type of development ensures that their product is both safe and accurate, despite the intense competition that appears to surround the production of the first widely approved fully non-invasive continuous glucose monitor (CGM).
University of Washington and UW Medicine researchers may have identified a method for earlier detection of prediabetes in April 2023. A novel system was developed by the group, which measures blood glucose levels using the capacitive touch-sensing capabilities of any smartphone—no need for a separate reader. Standard screening protocols entail a laboratory examination at a medical facility or the implementation of a portable glucometer for continuous monitoring at home. Cost and accessibility are barriers to widespread screening. According to the findings of the study, the precision of GlucoScreen is similar to that of traditional glucometer testing. The accuracy of the system was identified by the team at the critical threshold that separated prediabetes, characterized by a blood glucose level between 100 and 125 mg/dL, from normal blood glucose levels of 99 mg/dL or less.
February 2023: Zoetis has declared that the AlphaTrak 3 blood glucose monitoring system for diabetic canines and felines will be available in the United States beginning in February 2023. For the purpose of enhancing diabetic pet care, this iteration of the AlphaTrak incorporates a novel mobile application that facilitates smooth and uncomplicated communication and sharing of supplementary information and glucose readings of a pet in real-time with the veterinary practice. Veterinarians are equipped with precise data through the innovative AlphaTrak 3 blood glucose monitoring system, enabling them to administer optimal medical treatment with confidence.
Roche Diabetes Care India (RDC India) has said that it in May 2023 manufactures Accu-Chek Active blood glucose monitoring device and test strips in India. They are doing this in partnership with Parekh Integrated Services Pvt. Ltd. (PISPL), who serve as the assembly and distribution partners, and their manufacturing partner Sanmina-SCI India Pvt. Ltd., as part of the company’s goal to increase access to diabetes care and meet the rising demands of the Indian market.
OmegaQuant has launched a home testing kit for HbA1c blood sugar in May 2022, which enables customers to see their hemoglobin A1c levels so that they can break down glucose. Ordinarily, HbA1c testing needs a blood draw plus lab analysis; however, OmegaQuant’s HbA1c test is done via a simple finger stick, thus offering enough time flexibility for customers to carry out the test at home when they can.
The Ministry of Health Canada revised payment regulations for blood glucose test strips under the Ontario Drug Benefit (ODB) Program Health Network System (HNS) in March 2022. HNS will apply an annual maximum quantity limit for blood glucose test strips using online claims or documents submitted by ODB-eligible patients.
An HbA1c home-testing kit for measuring HbA1c blood sugar was introduced by OmegaQuant, which allows individuals to measure their Hemoglobin A1C (Hgb) level so as to metabolize glucose in May 2022. Usually, HbaIC tests involve drawing blood and taking it to a lab, but Omega Quant’s HbaIC test simply requires you to prick your finger with no extra effort, meaning that users are allowed to take these tests whenever they want, right from their homes.
Global Blood Glucose Test Strip Market Trends
-
Utilization of Point-of-care testing for diabetes is a growing trend shaping the market and creating new opportunities.
The global blood glucose test strip market is poised to experience substantial expansion due to the growing trend of utilizing point-of-care testing. Point-of-care testing enables immediate, on-site analyses of blood glucose levels to be performed, eliminating the necessity for laboratory processing and ensuring the provision of accurate, timely results. There are numerous advantages associated with this methodology, encompassing convenience, expedited response times, and immediate modifications in strategies for managing diabetes. The capacity of point-of-care testing to provide prompt and accurate results is the reason for its widespread use. The conventional approach to laboratory testing may entail extended waiting periods for results, thereby impeding the ability to make prompt decisions concerning the management of diabetes. With the one-touch blood glucose test strip, patients can have their blood glucose levels assessed at the point of care facilities within minutes. If necessary, they can make immediate adjustments to their nutrition, exercise regimen, or medication. This form of feedback enables individuals diagnosed with diabetes to effectively self-manage their condition and promptly make informed decisions regarding their health.
Point-of-care testing facility not only offers convenience and efficiency but also provide practical advantages for healthcare providers and medical institutions. It provides healthcare professionals with vital information regarding diagnosis, therapy adjustments, and monitoring of patients' blood glucose levels during clinic visits. Point-of-care tests streamline processes, enhance the efficiency of patient care, and eliminate the need for laboratory referrals. Healthcare facilities, including hospitals, clinics, and ambulatory surgical centres, are progressively incorporating point-of-care testing into their established clinical practices to enhance the patient experience and optimise healthcare delivery.
Global Blood Glucose Test Strip Market Segment Insights
The global blood glucose test strip market is primarily segmented by technology, product type, and end-user insights.
Blood Glucose Test Strip Technology Insights
The blood glucose test strip market when segmented based on technological insights, is further bifurcated into electrochemical, enzymatic and colourimetric, where the electrochemical sub-segment owns the larger portion of the market share, due to the high accuracy it offers and the ease of testing that such electrochemical strip offer.
Blood Glucose Test Strip Product Type Insights
The blood glucose test strip market when segmented based on product types, is further divided into blood test strip and urine test strip, where the blood test strip accumulate the larger market share and is also anticipated to register a higher CAGR during the forecast period 2024 to 2032. The Easy-Touch glucose test strip quantify the concentration of glucose in a finger puncture of blood. By inserting the test strip into a blood glucose meter, the quantity of glucose in the blood sample is determined. By observing the data presented on the screen of the meter, the patient can monitor the evolution of their blood sugar levels.
Blood Glucose Test Strip End-User Insights
Based on End-User segmentation, the blood glucose test strip market is further divided into hospitals, diagnostics centres, nursing homes and others. Out of these, the hospital sub-segmentation owes the major market share. In addition, purchasing groups are utilized by hospitals and clinics to acquire test strip in quantity. Since the inception of the COVID-19 pandemic, these devices have been the most frequently employed in public and private settings to identify hyperglycaemia, hypoglycaemia, and glycaemic variations.
Blood Glucose Test Strip Regional Insights
The global blood glucose test strip market is primarily studied across four major reasons namely, North America, Europe, Asia-Pacific and the Rest of the World. Among these prominent regions, the North American region holds the major market share of the said market segment, and the Asia-Pacific region is said to have the highest CAGR during the forecast period.
Several factors are driving the North American market forward which include the rising incidence of diabetes, the initiatives of the national government to combat the disease more broadly, the rising prevalence of test strip, and the presence of significant market players. The United States is anticipated to retain the largest market share in North America. According to data updated by the CDC in January 2022, diabetes affected 37.3 million individuals, or 11.3%, of the US population. In the previous year, the disease affected 28.7 million people, including 28.5 million adults, in the country. It is anticipated that this demographic will propel the demand for diabetes test strip and stimulate regional market expansion.
The Europe test strip market holds the second largest market share as a result of the region's high prevalence of chronic diseases and the government's increasing support, which is demonstrated through increased investments in the construction of hospitals equipped with modern technology. Furthermore, it was reported that the German market held the largest proportion of the test strip industry, while the United Kingdom market is regarded as the most rapidly expanding market in Europe.
Apart from these two regions, the Asia-Pacific region is said to be the fastest-growing region with the highest CAGR during the period of forecast. The significant increase in diabetes prevalence among the APAC nations is a key driver of market revenue expansion. Based on data from the IDF Atlas, the prevalence of diabetes in India was estimated to be at 92.9 million by 2032, up from 74.1 million in 2021.
Global Blood Glucose Test Strip Market Key Players & Competitive Insights
The global blood glucose test strip market is moderately fragmented, with several significant companies operating at both the international and regional levels. To strengthen their positions in the global market and develop their respective portfolios, key players in the market are conducting clinical trials and developing products and medical devices, as well as forming strategic alliances and agreements with global leaders in the said domains. Dario Health Corporation, LifeScan, Inc., ARKRAY, Inc., Medtronic plc, Bionime Corporation, and Care Touch LLC are among the key companies profiled in the said market segment.
Global Blood Glucose Test Strip Market Key Companies
- Abbott Laboratories
- Acon Laboratories. Inc
- Allmedicus
- Apex Biotechnology Corporation
- Ascensia Diabetes Care Holdings Ag
- Braun Melsungen Ag
- HMD Biomedical
- I-Sens, Inc.
- Lifescan, Inc.
- Roche Diagnostics
- Taidoc Technology Corporation
- Agamatrix
- Nipro
- 77 Electronika
Recent Developments
May 2022:In May 2022, OmegaQuant a leading company in the said market introduced HbA1c blood sugar at-home testing kit, that helps their customers to test their blood sugar and haemoglobin levels easily and at their convenience. It allows one to check the blood with a simple finger stick to conduct the test on their own in their own comfort zone.
March 2022:In March 2022, Virtual Diabetics Clinic 9 am Health, signed a partnership deal with Ascensia Diabetes Care that allows it to add the contour next one blood glucose meter to its test toolkit.
February 2021:In February 2021, Roche a leader in the said market segment introduced the Accu-Check Instant system, which is a new connected blood glucose monitoring solution.
| Report Attribute/Metric | Details |
| Market Size 2032 | USD 33.80 billion |
| Compound Annual Growth Rate (CAGR) | 7.43% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 & 2020 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technology and Region |
| Geographies Covered | North America, Europe, Asia-Pacific and the Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Abbott Laboratories, Acon Laboratories. Inc, Allmedicus, Apex Biotechnology Corporation, Ascensia Diabetes Care Holdings Ag, B.Braun Melsungen Ag, HMD Biomedical, I-Sens, Inc., Lifescan, Inc., Roche Diagnostics, Taidoc Technology Corporation, Agamatrix, Nipro, 77 Electronika |
| Key Market Opportunities | Demand for diabetes test strip and stimulate regional market expansion. |
| Key Market Dynamics | Utilization of Point-of-care testing for diabetes is a growing trend shaping the market and creating new opportunities. |
Global Blood Glucose Test Strip Market Highlights:
Frequently Asked Questions (FAQ) :
Global Blood Glucose Test Strip Market size can touch a valuation of USD 33.80 Billion by 2032.
Global Blood Glucose Test Strip Market is expected to accrue revenues at a CAGR of 7.43% from 2024-2032.
Heavy prevalence of diabetes is the major growth driver of the Global Blood Glucose Test Strip Market.
Global Blood Glucose Test Strip Market growth can be hampered by inadequate reimbursement schemes.
North America is the best-performing region within the Global Blood Glucose Test Strip Market.
TaiDoc, AgaMatrix Inc, Jiangsu Yuyue, Elektronika, Nipro Diagnostics, Abbott, ACON Laboratories, SANNUO, HMD BioMedical Inc., Beijing Yicheng Electronics, i-SENS, Betachek National Diagnostics, LifeScan, Universal Biosensors, Roche Diagnostics, B. Braun, Bayer Diabetes Care, Apex Biotechnology Corp, Shanghai MicroSense, and ALL Medicus are some of the biggest players in the Global Blood Glucose Test Strip Market.
Leading companies partner with us for data-driven Insights
